Light-activated, photosensitizer-based therapies have been established as safe modalities
of tumour ablation for numerous cancer indications. Two main approaches are available …

Basal cell carcinoma (BCC) is the most common malignant tumour in white populations.
Multidisciplinary experts from the European Dermatology Forum, the European Association …

Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a
photochemical reaction between a light activatable molecule or photosensitizer, light, and …

Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually
increasing annual incidence in the United States. When diagnosed early, the majority of …

Photodynamic therapy (PDT), a non-invasive therapeutic modality, has received increasing
attention owing to its high selectivity and limited side effects. Although significant clinical …

Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic
procedure that can exert a selective cytotoxic activity toward malignant cells. The procedure …

Skin cancer is a global threat to the healthcare system and is estimated to incline
tremendously in the next 20 years, if not diagnosed at an early stage. Even though it is …

Basal cell carcinoma (BCC) of the skin is the most common cancer, with a higher incidence
than all other malignancies combined. Although it is rare to metastasize, patients with …

Photodynamic therapy (PDT) utilizes a sensitizer agent and light to produce selective cell
death. Dermatologists are familiar with PDT for the treatment of actinic keratoses and early …

A myriad of naturally occurring and synthetic structures are capable of transferring the
energy of light. Few, however, allow for this energy transfer to enable a type II photochemical …